Oregon announces Recall of Pet Food Due to HPAI Contamination
On Dec. 26, 2024, the Oregon Department of Agriculture (ODA) announced it is alerting pet owners that samples…
On Dec. 26, 2024, the Oregon Department of Agriculture (ODA) announced it is alerting pet owners that samples…
On Nov. 16, 2022, the Cancer Prevention and Research Institute of Texas (CPRIT) approved $12 million in recruitment…
On Feb. 2, 2022, a new analysis of the first two patients treated in a clinical trial with…
On Jan. 13, 2022, OraSure Technologies that its InteliSwabᆴ COVID-19 rapid tests detected the Omicron variant as effectively…
On Nov. 30, 2021, Inovio Pharma announced the company was rapidly moving to evaluate its COVID-19 DNA vaccine…
On Nov. 9, 2021, Inovio Pharma announced that the U.S. Food and Drug Administration (FDA) provided authorization to…
On Jan. 26, 2021, OraSure Technologies announced that Chronomics had selected the OMNIgene-ORAL (OME-505) saliva collection device as…
On Jan. 21, 2021, Penn Medicine reported that patients with inactive cancer and not currently undergoing treatments also…
On Jan. 19, 2021, Cue Health announced that its molecular, point-of-care COVID-19 Tests were being distributed to five…
On Jan. 4, 2021, Inovio Pharmaceuticals and Advaccine Biopharmaceuticals announced that they had entered into a collaboration and…
On Dec. 24, 2020, Inovio Pharmaceuticals announced publication of peer-reviewed Phase 1 clinical data from the first cohort…
On Dec. 21, 2020, OraSure Technologies disclosed that the FDA had requested additional information as part of its…
On Dec. 7, 2020, Inovio Pharmaceuticals announced it had dosed its first subject in a Phase 2 clinical…
On Dec. 3, 2020, Inovio Pharmaceuticals announced the execution of an agreement with Kaneka Eurogentec an affiliate of…
On Nov. 16, 2020, INOVIO announced that it had received clearance from the the U.S. Food & Drug…
On Dec. 11, 2019, Seqirus announced that its cell-based quadrivalent influenza vaccine (QIVc) had received approval from Health…
On Oct. 7, 2019, Penn Medicine announced it had developed gene therapy to treat Duchenne muscular dystrophy (DMD)…
On Nov. 18, 2015, the estate of Glenn Korff gifted $5 million to the Fred & Pamela Buffett…
On Dec. 12, 2014, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had approved the supplemental…
In Feb. 2013, the Center for Personalized Diagnostics (CPD) was established at UPenn for researching genomic and therapeutic…
In 2012, the Basser Center for BRCA was established at Penn Medicine’s Abramson Cancer Center to establish a…
In 1990, the University of Pittsburgh Cancer Institute received National Cancer Institute (NCI) Comprehensive designation. The University of…
In 1981, Dr. Alexa Canady became the first African American woman in the U.S. to become a neurosurgeon,…
Om Mar. 28, 1979,the Three Mile Island Unit 2 (TMI-2) reactor, near Middletown, Pa., partially melted down resulting…
On Nov. 21, 1977, the U.S. Food and Drug Administration (FDA) licensed the first pneumococcal vaccine containing 14…
In 1972, the Pennsylvania Association for Retarded Children v. Commonwealth of Pennsylvania and Mills v. Board of Education…
In 1972, The Wistar Institute was designated the first National Cancer Institute (NCI) Cancer Center in basic research…
In 1968, the University of Pennsylvania Institute for Environmental Medicine was established in recognition of the increasing need…
In 1967, the American Chemical Society awarded the Priestley Medal to Ralph Connor “to recognize distinguished services to…
In 1967, H. Keffer Hartline, born in Bloomsburg, Pennsylvania and graduate of Layfayette College in Easton, PA (B.Sc….